Developmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA.
NorCal CarciNET Community, Oakland, California, USA.
Endocr Relat Cancer. 2023 Jun 21;30(7). doi: 10.1530/ERC-22-0226. Print 2023 Jul 1.
This serves as a white paper by the North American Neuroendocrine Tumor Society (NANETS) on the practical considerations when providing palliative care to patients with neuroendocrine tumors in the context of routine disease management or hospice care. The authors involved in the development of this manuscript represent a multidisciplinary team of patient advocacy, palliative care, and hospice care practitioners, endocrinologist, and oncologists who performed a literature review and provided expert opinion on a series of questions often asked by our patients and patient caregivers affected by this disease. We hope this document serves as a starting point for oncologists, palliative care teams, hospice medical teams, insurers, drug manufacturers, caregivers, and patients to have a frank, well-informed discussion of what a patient needs to maximize the quality of life during a routine, disease-directed care as well as at the end-of-life.
这是北美神经内分泌肿瘤学会(NANETS)发布的一份白皮书,内容涉及在常规疾病管理或临终关怀背景下为神经内分泌肿瘤患者提供姑息治疗时的实际考虑因素。参与本手稿编写的作者代表了一个多学科团队,包括患者权益倡导者、姑息治疗和临终关怀从业者、内分泌学家和肿瘤学家,他们对一系列经常被我们的患者及其受该疾病影响的患者护理人员提出的问题进行了文献回顾,并提供了专家意见。我们希望本文件能够成为肿瘤学家、姑息治疗团队、临终关怀医疗团队、保险公司、药品制造商、护理人员和患者的起点,以便就患者在常规疾病导向治疗期间以及生命末期最大化生活质量所需的内容进行坦诚、知情的讨论。